Concepedia

Shirisha Jonnalagadda

SJ

Statistics

Publications

10

Citations

221

H-Index

10

Active since

2019

Affiliations

University of Minnesota, Duluth(Current)

University of Nebraska Medical Center

Texas Tech University

University of Ha'il

Texas Tech University Health Sciences Center

Shirisha Jonnalagadda is an author at University of Minnesota, Duluth specializing in medicinal chemistry, drug discovery, and drug development.

ORCID

Top concepts

Publications per year

2019–2023

10

Publications

10

Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells

Chinnadurai Mani, Shirisha Jonnalagadda, Jojireddy Lingareddy et al. · Breast Cancer Research · 2019 · 66 citations · Full text

Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors

Shirisha Jonnalagadda, Sravan K. Jonnalagadda, Conor T. Ronayne et al. · Oncotarget · 2019 · 34 citations · Full text

A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma

Ali Khammanivong, Jhuma Saha, Angela Spartz et al. · Veterinary and Comparative Oncology · 2019 · 20 citations

Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment

Grady L. Nelson, Conor T. Ronayne, Lucas N. Solano et al. · Scientific Reports · 2019 · 20 citations · Full text

, , +16

Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents

Lucas N. Solano, Grady L. Nelson, Conor T. Ronayne et al. · Scientific Reports · 2020 · 16 citations · Full text

1–5 of 10